Science and Research
Scientific research is a vital and strategically important part of Masaryk Memorial Cancer Institute activities. It is statutorily embedded in MMCI regulations. Moreover, research is one of the main activities for which our organization was established. Thus, MMCI a unique center in the Czech Republic which hosts under one roof both basic and applied research in the field of oncology and related biomedical fields. MMCI has its own research facility and it also participates in numerous domestic and international cooperation projects.
1Focus of science and research
The MMCI scientific program focuses on six key topics:
- Precision oncology in the field of prevention, diagnosis, surgical, radiation and pharmacologic cancer treatment
- Translational research in molecular oncology and genetics
- Immune system and cancer
- Aging and cancer
- Supporting expert systems in oncology
- Project connectivity in EU
2Direction of Science and Research
- Independent researchers (introduced in attachment) covering basic, translational, as well as clinical research provide feedback on research in the MMCI, discuss relevant indicators of further development and recommend a strategy for further development.
- The Division of Science and Research at MMCI has two advisory bodies - the Scientific Board (held twice a year) and the Clinical Research Council (meets regularly once a month). The Division is composed from several independent units - the Bank of Biological Material, the Research Center for Applied Molecular Oncology (RECAMO), Project Administration Office, Project Support Office and, last but not least, the activities of the Scientific Secretary.
3Contacts
You can send us your requests and questions in the field of research
E [obfuscate_1_|117|112|117|107|108|108|55|104|111|108|45|90|117]
Management →
Director for Science and Research
doc. MUDr. Tomáš Kazda, Ph.D.Staff →
Director of Research Center for Applied Molecular Oncology (RECAMO)
RNDr. Bořivoj Vojtěšek, DrSc.
Executive Director of the Bank of Biological Material
doc. Mgr. Roman Hrstka, Ph.D.
Scientific Secretary, MMCI
prof. RNDr. Ondřej Slabý, Ph.D.
Head of the Project Support Office, MMCI
doc. Mgr. Jiří Šána, Ph.D.
Head of the Project Administration Office, MMCI
Head of the Project Administration Office, MMCI4RECAMO
The Research Center for Applied Molecular Oncology (RECAMO) is a modern research institute focusing on cancer biology.
5Bank of Biological Material
The Bank of Biological Material (BBM) stores long-term frozen tissues or tissues processed otherwise and other human biological material originating from MMCI cancer patients. The samples are thus used, including relevant clinical information, primarily for research projects.
6 Scientific Secretary
The Scientific Secretary shall ensure the organization and management of the Scientific Board. He/she participates in the organization of scientific work and creates new strategies and conceptual development of science and research in MMCI.
Scientific Secretary →
7Scientific Board
The Scientific Board is an advisory body to the Director in matters of science and research carried out in MMCI, including conceptual and strategic direction. The Scientific Board discusses and gives an opinion mainly on projects solved within the framework of grant support, including projects financed from institutional support.
Topics discussed at the spring meeting →
- Information on IPO for the given year (presentation of overall drawing plan).
- Presentation of projects financed from IPO for the given year.
- Presentation of final reports and evaluation of projects financed by an external grant agency, the implementation of which was completed in the previous year (individual presentations of individual researchers / co-researchers).
- Presentation of new projects funded by external grant agencies.
- Presentation of current academic studies taking place in MMCI.
- MMCI publication activity in the previous year.
Topics discussed at the autumn meeting →
- Progress of IPO projects implementation. Presentation of final results of projects that were financed from IPO (including individual presentations of researchers in case of completed PPVs).
- Presentation of new projects funded by external grant agencies.
- Analysis of unsuccessful applications to external grant competitions in the previous year.
- Projects of doctoral studies/educations.
- Information on status of projects in RECAMO, BBMRI and other projects.
- Plan for IPO drawing for the following year.
Members of the Scientific Board 2022 →
- Ing. et Ing. Jan Adam, Ph.D.
- Department of Nuclear Medicine, MMCI
- doc. MUDr. Oldřich Coufal, Ph.D.
- Department of Surgical Oncology, MMCI, Medical Chief
- Division of Breast, Skin and Oncoplastic Surgery, MMCI, Medical Chief
- doc. MUDr. Regina Demlová, Ph.D.
- Clinical Trials Unit, MMCI, Head of the Department
- doc. MUDr. Jan Doležel, Ph.D.
- Department of Urologic Oncology, MMCI, Medical Chief
- prof. RNDr. Ladislav Dušek, Ph.D.
- Head of the Institute of Biostatistics and Analyses FM MU
- Mgr. Jakub Dvořáček, MHA
- Association of Innovative Pharmaceutical Industry (AIFP), Director
- doc. MUDr. Vuk Fait, CSc
- Department of Surgical Oncology, MMCI, Head of the Department
- Division of Breast, Skin and Oncoplastic Surgery, MMCI, Deputy Medical Chief
- doc. MUDr. Lenka Foretová, Ph.D.
- Department of Cancer Epidemiology and Genetics, MMCI, Medical Chief — Head of the Department
- doc. MUDr. Marián Hajdúch, Ph.D. /BIOMEDREG/
- The Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Director
- MUDr. Jana Halámková, Ph.D.
- Department of Comprehensive Cancer Care, Cancer Prevention Center, MMCI, Head of the Department
- prof. Ing. Lenka Hernychová, Ph.D.
- Research Center for Applied Molecular Oncology (RECAMO), Head of the Research Group
- doc. Mgr. Roman Hrstka, Ph.D.
- Research Center for Applied Molecular Oncology (RECAMO), Head of the Research Group
- Executive Director of the Bank of Biological Material
- prof. MUDr. Zdeněk Kala, CSc
- Department of Surgery, University Hospital Brno, Head of the Department
- doc. MUDr. Tomáš Kazda, Ph.D.
- Director for Science and Research, MMCI
- doc. MUDr. Igor Kiss, Ph.D., MBA
- Director for Medical Care, MMCI
- Department of Comprehensive Cancer Care, MMCI, Head of the Department
- prof. RNDr. Jana Klánová, Ph.D.
- RECETOX Faculty of Science, Masaryk University, Director of the Center
- MUDr. Rudolf Nenutil, CSc.
- Department of Pathology, MMCI
- prof. RNDr. Šárka Pospíšilová, Ph.D.
- CEITEC MUNI, Head of the Research Center, Head of the Research Group
- Vice-rector for Research and Doctoral Studies at Masaryk University
- prof. RNDr. Ondřej Slabý, Ph.D.
- CEITEC MUNI, Head of the Research Center, Head of the Research Group
- Department of Biology, FM MU, Head of the Department
- Scientific Secretary, MMCI
- prof. MUDr. Martin Smrčka, Ph.D.
- Department of Neurosurgery, University Hospital Brno, Head of the Department
- Director for Science, Research and Education, FN Brno
- doc. PhDr. Miroslav Světlák, Ph.D.
- Head of the Department of Psychology and Psychosomatics, FM MU
- prof. MUDr. Marek Svoboda, Ph.D.
- Masaryk Memorial Cancer Institute, Director
- Mgr. Jiří Šána, Ph.D.
- CEITEC MUNI, Specialized researcher
- Head of the Project Support Office, MMCI
- prof. MUDr. Aleksi Šedo, DrSc
- Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University
- doc. MUDr. Roman Šefr, Ph.D.
- Division of Surgical Oncology, MMCI
- Department of Surgical Oncology, MMCI
- prof. MUDr. Pavel Šlampa, CSc.
- Department of Radiation Oncology, MMCI, Head of the Department
- prof. MUDr. Radek Špíšek, Ph.D.
- Department of Immunology, Second Faculty of Medicine, Charles University
- prof. MUDr. Jaroslav Štěrba, Ph.D.
- University Hospital Brno, Director
- RNDr. Bořivoj Vojtěšek, DrSc.
- Research Center for Applied Molecular Oncology (RECAMO)
- RECAMO Scientific Director, Head of the Research Group
- prof. MUDr Rostislav Vyzula, CSc.
- Department of Comprehensive Cancer Care, MMCI
- prof. MUDr Jan Žaloudík, CSc.
- Department of Surgical Oncology, MMCI
- Strategy and Innovation Office
Emeritus members of the Science Board
- prof. RNDr. et PharmDr. Jan Kovařík, DrSc.
- RNDr. Ludmila Lauerová, CSc.
- MUDr. Zdeněk Mechl, CSc.,
- MUDr. Tačo Tačev, CSc.
- RNDr. Ivan VerMOÚsek, CSc
8Clinical Research Council
The MMCI Clinical Research Council (hereinafter referred to as the CRC) is a body of the Director for Science and Research, which is established to support the development of MMCI scientific research activities, internal coordination, registration and supervision of these activities.
Activities of the Clinical Research Council →
- It sets priorities in the field of applied research and proposes internal rules dealing with the implementation of these projects to MMCI management,
- discusses interim and final reports on the progress of research, development and educational projects and outputs from internal and external inspections of these projects and proposes possible measures to MMCI management,
- sets priorities for transfer of knowledge from research to clinical practice and for the development of laboratory examination methods.
Dates of the Clinical Research Council meetings in 2021 →
|
|---|
9Project Support Office
Project Support Office provides consulting services and methodological guidance in preparation of new research projects, which are applied to internal and external grant schemes. It also provides consulting services to researchers in research implementation. It provides the organizational backup to MMCI Clinical Research Council.
Management →
Head of the Project Support Office, MMCI
doc. Mgr. Jiří Šána, Ph.D.
10Project Administration Office
Provides administrative activities for support of ongoing research projects. Administratively ensures the application for new grant project proposals. Collaborates with researchers in ensuring the implementation of individual projects.
Management →
Head of the Project Administration Office, MMCI
Ing. Zuzana Kuncová
12MMCI grants
The MMCI is actively involved in projects of research, education and development. Further information about grants can be found in the Czech version in the download files.
Science and Research
Free Cancer Helpline
Monday – Friday from 7.30 AM to 3.00 PMn
(+420)800 222 322